Azamat Omargali
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Azamat Omargali has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Aizhan Akhayeva
Department of Cell Technologies and Transplantation, JSC “National Scientific Medical Center”, Astana, Kazakhstan
1 shared publication - Alexander Gulyayev
National Laboratory Astana, Center for Life Sciences, Nazarbayev University, Astana 010000, Kazakhstan
1 shared publication - Anastasia Ganina
National Scientific Medical Center, Astana 010009, Kazakhstan
1 shared publication Astana Medical University
1 shared publicationEvgeniy Kamyshanskiy
Karaganda Medical University
1 shared publication- Irina Valerievna Palamarchuk
School of Natural Sciences, Tyumen State University, 15a Perekopskaya St., Tyumen 625003, Russia
1 shared publication
Latest Publications
- 31 August 2026
- Published by NpJSC "Astana Medical University" in Astana Medical Journal
- Vol. 126 (4)
Investigation of the Antifibrotic Activity of a Pentasubstituted Cyclohexanol Derivative in an Experimental Rat Model of Pulmonary Fibrosis Induced by Intratracheal Bleomycin Administration
Objective. To evaluate the antifibrotic effect of pentasubstituted cyclohexanol derivative 1 in an experimental rat model of pulmonary fibrosis induced by intratracheal administration of bleomycin. Methods. Pulmonary fibrosis was induced in rats by a single intratracheal administration of bleomycin. Animals in the experimental group received the synthesized compound 1 intragastrically at a dose of 50 mg/kg once daily for 2 weeks, starting 1 week after bleomycin administration. Histological sections were stained with hematoxylin and eosin to assess general histomorphometric characteristics, Masson’s trichrome to detect fibrosis and identify collagen fibers, and Gomori’s silver impregnation method to visualize reticulin fibers. The grade and stage of pulmonary tissue fibrosis were assessed. Results. In the group treated with compound 1, the mean area of fibrotic lung lesions was significantly smaller than that in the control group. In the control group, the histological pattern of fibrotic tissue was characterized by a relative predominance of mature type I collagen in areas of pulmonary tissue fibrosis. In the group treated with compound 1, the histological pattern of fibrotic tissue was characterized by a predominance of resorbable immature type III collagen fibers (reticulin). Chronic active inflammation was detected in 100% of cases in the control group. In contrast, no active chronic inflammatory process was detected in any case in the group treated with compound 1. Conclusions. Compound 1 used in this experimental study exhibits antifibrotic and anti-inflammatory effects and improves the locoregional histoarchitecture of lung tissue. Keywords: pentasubstituted cyclohexanol derivative, pulmonary fibrosis, bleomycin, blood rheology, hyperviscosity.
- 31 August 2026
- Published by NpJSC "Astana Medical University" in Astana Medical Journal
- Vol. 126 (4)
Investigation of the Antifibrotic Activity of a Pentasubstituted Cyclohexanol Derivative in an Experimental Rat Model of Pulmonary Fibrosis Induced by Intratracheal Bleomycin Administration
Objective. To evaluate the antifibrotic effect of pentasubstituted cyclohexanol derivative 1 in an experimental rat model of pulmonary fibrosis induced by intratracheal administration of bleomycin. Methods. Pulmonary fibrosis was induced in rats by a single intratracheal administration of bleomycin. Animals in the experimental group received the synthesized compound 1 intragastrically at a dose of 50 mg/kg once daily for 2 weeks, starting 1 week after bleomycin administration. Histological sections were stained with hematoxylin and eosin to assess general histomorphometric characteristics, Masson’s trichrome to detect fibrosis and identify collagen fibers, and Gomori’s silver impregnation method to visualize reticulin fibers. The grade and stage of pulmonary tissue fibrosis were assessed. Results. In the group treated with compound 1, the mean area of fibrotic lung lesions was significantly smaller than that in the control group. In the control group, the histological pattern of fibrotic tissue was characterized by a relative predominance of mature type I collagen in areas of pulmonary tissue fibrosis. In the group treated with compound 1, the histological pattern of fibrotic tissue was characterized by a predominance of resorbable immature type III collagen fibers (reticulin). Chronic active inflammation was detected in 100% of cases in the control group. In contrast, no active chronic inflammatory process was detected in any case in the group treated with compound 1. Conclusions. Compound 1 used in this experimental study exhibits antifibrotic and anti-inflammatory effects and improves the locoregional histoarchitecture of lung tissue. Keywords: pentasubstituted cyclohexanol derivative, pulmonary fibrosis, bleomycin, blood rheology, hyperviscosity.
- 27 February 2026
- Published by NpJSC "Astana Medical University" in Astana Medical Journal
- Vol. 126 (1) , amj006
Mesenchymal Stem Cells in Regenerative Therapy: Therapeutic Potential and Applications
The purpose of this review is to provide an updated overview of the potential use of mesenchymal stem cells (MSCs) in regenerative medicine. MSCs can be isolated from various tissues, and their biological properties largely depend on their source. Bone marrow-derived MSCs remain the most studied and widely used; however, their use is limited by the invasive nature of their collection, low cell yield, and age-related decline in regenerative potential. The human placenta offers an alternative source of MSCs for drug research and development due to its high availability, the ability to obtain large numbers of cells, and low immunogenicity. This review aims to summarize current literature data on the regenerative properties of human bone marrow and placental mesenchymal stem cells and to compare their potential for use in regenerative medicine. Keywords: mesenchymal stem cells, regenerative cell therapy, bone marrow-derived mesenchymal stem cells, placental mesenchymal stem cells.
- 27 February 2026
- Published by NpJSC "Astana Medical University" in Astana Medical Journal
- Vol. 126 (1) , amj006
Mesenchymal Stem Cells in Regenerative Therapy: Therapeutic Potential and Applications
The purpose of this review is to provide an updated overview of the potential use of mesenchymal stem cells (MSCs) in regenerative medicine. MSCs can be isolated from various tissues, and their biological properties largely depend on their source. Bone marrow-derived MSCs remain the most studied and widely used; however, their use is limited by the invasive nature of their collection, low cell yield, and age-related decline in regenerative potential. The human placenta offers an alternative source of MSCs for drug research and development due to its high availability, the ability to obtain large numbers of cells, and low immunogenicity. This review aims to summarize current literature data on the regenerative properties of human bone marrow and placental mesenchymal stem cells and to compare their potential for use in regenerative medicine. Keywords: mesenchymal stem cells, regenerative cell therapy, bone marrow-derived mesenchymal stem cells, placental mesenchymal stem cells.
- 31 October 2025
- Published by NpJSC "Astana Medical University" in Astana Medical Journal
- Vol. 125 (5)
Training ABA Therapy Specialists: Global Evidence and the Kazakhstan Context
This article reviews recent evidence on effective training models for Applied Behavior Analysis (ABA) specialists, comparing traditional, blended, and telehealth-based approaches. The analysis highlights that competency-based training with structured supervision ensures high-quality professional preparation. Traditional in-person training remains the gold standard for skill acquisition, while blended and telehealth models increase accessibility and sustainability—particularly relevant for Kazakhstan, where a shortage of qualified specialists persists. Implementing blended learning and tele-supervision could enhance the national capacity to deliver evidence-based behavioral interventions and promote inclusive education. The studyunderscores the importance of establishing national standards, certification systems, and academic collaboration to develop a sustainable ABA training framework in Kazakhstan.Key words:аpplied behavior analysis (ABA),professional training,blended learning,telehealth supervision,competency-based education,inclusive education,Kazakhstan,autism spectrum disorder (ASD).
- 31 October 2025
- Published by NpJSC "Astana Medical University" in Astana Medical Journal
- Vol. 125 (5)
Training ABA Therapy Specialists: Global Evidence and the Kazakhstan Context
This article reviews recent evidence on effective training models for Applied Behavior Analysis (ABA) specialists, comparing traditional, blended, and telehealth-based approaches. The analysis highlights that competency-based training with structured supervision ensures high-quality professional preparation. Traditional in-person training remains the gold standard for skill acquisition, while blended and telehealth models increase accessibility and sustainability—particularly relevant for Kazakhstan, where a shortage of qualified specialists persists. Implementing blended learning and tele-supervision could enhance the national capacity to deliver evidence-based behavioral interventions and promote inclusive education. The studyunderscores the importance of establishing national standards, certification systems, and academic collaboration to develop a sustainable ABA training framework in Kazakhstan.Key words:аpplied behavior analysis (ABA),professional training,blended learning,telehealth supervision,competency-based education,inclusive education,Kazakhstan,autism spectrum disorder (ASD).